Explore stories from Atlantic Canada.
Ecology Action Centre calls for immediate implementation of Coastal Protection Act | SaltWire - Boston Scientific's quarterly results on Thursday are likely to show the benefits of a rebound in elective procedures and help ease fears that the medical device maker could take a hit from the surging popularity of weight-loss drugs.
However, Boston Scientific is unlikely to see any pressure in the third quarter or in the near-term from GLP-1s due to its very small bariatric exposure, and a longer-term impact to its heart devices is unclear, analysts have said. Boston Scientific, which makes a major chunk of its revenue from sales of its heart devices, also makes devices to diagnose and treat a range of gastrointestinal and pulmonary conditions.
Analysts pointed to growing demand for the company's stroke prevention device, branded as Watchman, which is expected to become a blockbuster opportunity in the next few years.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
UAW expands strike against Stellantis, hitting pickup truck plantExplore stories from Atlantic Canada.
Read more »
EU lawmakers face struggle to reach agreement on AI rules -sourcesExplore stories from Atlantic Canada.
Read more »
Luxury slowdown further challenges Gucci revivalExplore stories from Atlantic Canada.
Read more »
Goodfellas gangster Vinny Asaro was fingered in $6M Lufthansa heistExplore stories from Atlantic Canada.
Read more »
Nova Scotia needs a plan to deal with escalating school violence, NDP saysExplore stories from Atlantic Canada.
Read more »
P.E.I. oysters recalled in the U.S. due to salmonella, E.coli concernsExplore stories from Atlantic Canada.
Read more »